A detailed history of F Dx Advisors, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, F Dx Advisors, Inc. holds 9,231 shares of BSX stock, worth $705,248. This represents 0.1% of its overall portfolio holdings.

Number of Shares
9,231
Previous 13,654 32.39%
Holding current value
$705,248
Previous $789,000 19.9%
% of portfolio
0.1%
Previous 0.06%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

SELL
$57.6 - $68.62 $254,764 - $303,506
-4,423 Reduced 32.39%
9,231 $632,000
Q4 2023

Feb 12, 2024

SELL
$48.64 - $57.81 $174,666 - $207,595
-3,591 Reduced 20.82%
13,654 $789,000
Q3 2023

Nov 02, 2023

BUY
$50.19 - $54.68 $21,129 - $23,020
421 Added 2.5%
17,245 $910,000
Q2 2023

Jul 17, 2023

BUY
$49.72 - $54.64 $390,351 - $428,978
7,851 Added 87.5%
16,824 $910,000
Q4 2022

Feb 09, 2023

BUY
$39.56 - $47.22 $41,063 - $49,014
1,038 Added 13.08%
8,973 $415,000
Q3 2022

Nov 10, 2022

SELL
$36.71 - $109.66 $99,410 - $296,959
-2,708 Reduced 25.44%
7,935 $307,000
Q2 2022

Aug 03, 2022

BUY
$35.24 - $47.1 $63,114 - $84,356
1,791 Added 20.23%
10,643 $397,000
Q1 2022

May 03, 2022

SELL
$40.9 - $45.1 $151,616 - $167,185
-3,707 Reduced 29.52%
8,852 $392,000
Q4 2021

Feb 01, 2022

BUY
$38.07 - $44.87 $125,364 - $147,756
3,293 Added 35.54%
12,559 $534,000
Q3 2021

Oct 08, 2021

BUY
$41.23 - $45.88 $42,590 - $47,394
1,033 Added 12.55%
9,266 $402,000
Q2 2021

Aug 05, 2021

BUY
$38.58 - $44.24 $317,629 - $364,227
8,233 New
8,233 $352,000
Q4 2020

Feb 08, 2021

SELL
$33.15 - $41.97 $1.17 Million - $1.48 Million
-35,360 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$34.44 - $42.23 $275,520 - $337,840
8,000 Added 29.24%
35,360 $1.35 Million
Q2 2020

Jul 22, 2020

BUY
$30.19 - $39.11 $510,935 - $661,897
16,924 Added 162.17%
27,360 $961,000
Q1 2020

May 22, 2020

SELL
$25.83 - $45.71 $123,157 - $217,945
-4,768 Reduced 31.36%
10,436 $341,000
Q1 2020

May 13, 2020

SELL
$25.83 - $45.71 $52,150 - $92,288
-2,019 Reduced 11.72%
15,204 $22,000
Q4 2019

Feb 12, 2020

BUY
$37.87 - $45.37 $237,823 - $284,923
6,280 Added 57.39%
17,223 $779,000
Q3 2019

Nov 07, 2019

SELL
$40.31 - $43.45 $32,409 - $34,933
-804 Reduced 6.84%
10,943 $445,000
Q2 2019

Jul 19, 2019

SELL
$34.91 - $42.98 $14,522 - $17,879
-416 Reduced 3.42%
11,747 $505,000
Q1 2019

May 14, 2019

SELL
$32.91 - $40.75 $32 - $40
-1 Reduced 0.01%
12,163 $467,000
Q4 2018

Apr 29, 2019

SELL
$31.73 - $39.04 $48,388 - $59,536
-1,525 Reduced 11.14%
12,164 $430,000
Q4 2018

Feb 07, 2019

BUY
$31.73 - $39.04 $84,909 - $104,471
2,676 Added 24.3%
13,689 $484,000
Q3 2018

Nov 13, 2018

SELL
$32.83 - $38.63 $45,994 - $54,120
-1,401 Reduced 11.29%
11,013 $424,000
Q2 2018

Aug 08, 2018

SELL
$26.84 - $34.32 $76,225 - $97,468
-2,840 Reduced 18.62%
12,414 $406,000
Q1 2018

May 02, 2018

SELL
$25.2 - $28.54 $110,779 - $125,461
-4,396 Reduced 22.37%
15,254 $417,000
Q4 2017

Feb 09, 2018

BUY
$24.79 - $29.8 $37,879 - $45,534
1,528 Added 8.43%
19,650 $487,000
Q3 2017

Nov 03, 2017

BUY
$26.26 - $29.17 $34,768 - $38,621
1,324 Added 7.88%
18,122 $529,000
Q2 2017

Aug 11, 2017

BUY
N/A
16,798
16,798 $466,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $109B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track F Dx Advisors, Inc. Portfolio

Follow F Dx Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.